Skip to main content

Table 3 Comparison of baseline characteristics patients who completed the study versus twice the number of propensity score-matched historical controls

From: Enhanced Telehealth Home-Monitoring Intervention for Vulnerable and Frail Patients after Cardiac Surgery (THE-FACS Pilot Intervention Study)

Characteristic, n (%)

Control (n = 42)

Completed (n = 21)

p-value

Demographic and risk factors

Age, years

66

 ± 7

68

 ± 5

0.29

Female sex

2

(4.8)

4

(19.0)

0.09

BMI < 18.5 or ≥ 35 kg/m2

7

(16.7)

3

(14.3)

1.00

Smoking history

29

(69.0)

15

(71.4)

0.85

Diabetes

20

(47.6)

12

(57.1)

0.48

Hypertension

40

(95.2)

19

(90.5)

0.60

Dyslipidemia

42

(100.0)

21

(100.0)

-

CVD

2

(4.8)

1

(4.8)

1.00

PVD

11

(26.2)

5

(23.8)

0.84

Renal failure

1

(2.4)

1

(4.8)

1.00

COPD

8

(19.0)

3

(14.3)

0.74

Pulmonary hypertension

0

(0.0)

0

(0.0)

-

Heart function

Atrial fibrillation

9

(21.4)

3

(14.3)

0.74

MI ≤ 21 days

3

(7.1)

1

(4.8)

1.00

LVEF < 40%

0

(0.0)

0

(0.0)

-

CHF

0

(0.0)

0

(0.0)

-

NYHA class 3–4

31

(73.8)

15

(71.4)

1.00

Surgery

Previous CV

7

(16.7)

3

(14.3)

1.00

Previous surgery

2

(4.8)

0

(0.0)

0.55

Urgent status

22

(52.4)

9

(42.9)

0.48

HCT < 24%

0

(0.0)

0

(0.0)

-

Procedure

     

CABG

37

(88.1)

17

(81.0)

0.72

Valve

3

(7.1)

3

(14.3)

 

CABG + valve

2

(4.8)

1

(4.8)

 
  1. Abbreviations: BMI Body Mass Index, CVD Cerebrovascular Disease, PVD Peripheral Vascular Disease, COPD Chronic Obstructive Pulmonary Disorder, MI Myocardial Infarction, LVEF Left Ventricle Ejection Fraction, CHF Congestive Heart Failure, NYHA New York Heart Association, HCT Hematocrit